Bio Green Med Solution, Inc.
BGMS· Nasdaq
BGMSBio Green Med Solution, Inc.
Released Aug 13, 2026, after the close
10-Q filed Aug 14, 2026, 45 days after period end · 0001493152-26-038393
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $336.00K | — | $4.00K | $373.00K |
| Net Income | -$405.00K | -$1.32M | -$3.26M | -$5.45M |
| EPS Diluted |
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR
| -$0.08 |
| -$0.98 |
| -$172.18 |
| -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
